These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin. Feliciano I; Matta J; Meléndez E J Biol Inorg Chem; 2009 Sep; 14(7):1109-17. PubMed ID: 19536567 [TBL] [Abstract][Full Text] [Related]
4. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone. Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells. Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505 [TBL] [Abstract][Full Text] [Related]
6. New titanocene derivatives with high antiproliferative activity against breast cancer cells. Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure, DNA/protein binding, and cytotoxic activity of a rhodium(III) complex with 2,6-bis(2-benzimidazolyl)pyridine. Esteghamat-Panah R; Hadadzadeh H; Farrokhpour H; Simpson J; Abdolmaleki A; Abyar F Eur J Med Chem; 2017 Feb; 127():958-971. PubMed ID: 27836194 [TBL] [Abstract][Full Text] [Related]
8. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity. Tzubery A; Tshuva EY Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents. Peri D; Meker S; Shavit M; Tshuva EY Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656 [TBL] [Abstract][Full Text] [Related]
10. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors. García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846 [TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxic activities, DNA- and BSA-binding studies of dinuclear palladium(II) complexes with different pyridine-based bridging ligands. Franich AA; Živković MD; Milovanović J; Arsenijević D; Arsenijević A; Milovanović M; Djuran MI; Rajković S J Inorg Biochem; 2020 Sep; 210():111158. PubMed ID: 32622215 [TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative activity and mechanism of action of titanocene dichloride. Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119 [TBL] [Abstract][Full Text] [Related]
17. Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line. Hernández R; Méndez J; Lamboy J; Torres M; Román FR; Meléndez E Toxicol In Vitro; 2010 Feb; 24(1):178-83. PubMed ID: 19772913 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure elucidation of novel salophen-based dioxo-uranium(VI) complexes: In-vitro and in-silico studies of their DNA/BSA-binding properties and anticancer activity. Ebrahimipour SY; Mohamadi M; Torkzadeh Mahani M; Simpson J; Mague JT; Sheikhshoaei I Eur J Med Chem; 2017 Nov; 140():172-186. PubMed ID: 28923384 [TBL] [Abstract][Full Text] [Related]
19. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand. Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070 [TBL] [Abstract][Full Text] [Related]
20. Anticancer activity and mode of action of titanocene C. Olszewski U; Claffey J; Hogan M; Tacke M; Zeillinger R; Bednarski PJ; Hamilton G Invest New Drugs; 2011 Aug; 29(4):607-14. PubMed ID: 20162321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]